Compare FCT & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FCT | STXS |
|---|---|---|
| Founded | 2004 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 245.5M | 210.0M |
| IPO Year | N/A | 2004 |
| Metric | FCT | STXS |
|---|---|---|
| Price | $10.04 | $2.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 106.8K | ★ 428.3K |
| Earning Date | 01-01-0001 | 11-11-2025 |
| Dividend Yield | ★ 11.29% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,075,000.00 |
| Revenue This Year | N/A | $24.48 |
| Revenue Next Year | N/A | $29.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 19.62 |
| 52 Week Low | $9.45 | $1.54 |
| 52 Week High | $10.42 | $3.59 |
| Indicator | FCT | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 68.80 | 42.57 |
| Support Level | $9.99 | $2.32 |
| Resistance Level | $10.07 | $2.42 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 92.55 | 42.00 |
First Trust Senior Floating Rate Income Fund II is a United States-based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, it attempts to preserve capital. The fund invests in a portfolio of senior secured floating-rate corporate loans (Senior Loans) of companies from different industries, such as Insurance, Software, Health Care Providers and Services, Professional Services, Health Care Technology, IT Services, and others.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.